Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Entera Appoints Ramesh Ratan as Chief Financial Officer
Entera Bio Ltd.April 15, 2021 GMT
BOSTON and JERUSALEM, Israel, April 15, 2021 (GLOBE NEWSWIRE) Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced the appointment of veteran finance and operations executive Ramesh Ratan as U.S. Chief Financial Officer. Mr. Ratan replaces Jonathan Lieber who was serving as Entera’s interim U.S. CFO.
Mr. Ratan brings 40 years of experience at biomedical, tech, and Fortune 500 companies in senior, executive, vice president, and C-level positions. He was most recently CFO, Head of Manufacturing, and Corporate Secretary at AOBiome. He served as CFO at Xcellerex, Enanta Pharmaceuticals, Repligen, and held positions at Bristol-Myers Squibb, American Superconductor, and Equinox Solutions. As CFO, he raised over $300 million an